SB387 - TO AUTHORIZE OFF-LABEL USE OF DRUG TREATMENTS TO TREAT MEDICAID BENEFICIARIES WITH PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION.
Bill Status History
4/13/2021 10:33:57 AM
Notification that SB387 is now Act 637
4/7/2021 10:42:44 AM
DELIVERED TO GOVERNOR.
4/7/2021 10:42:37 AM
Reported correctly enrolled and ordered delivered to the Governor.
4/6/2021 5:19:54 PM
4/6/2021 5:19:48 PM
Returned from the House as passed.
4/6/2021 2:37:57 PM
Returned To the Senate as passed.
4/6/2021 2:37:51 PM
Read the third time and passed and ordered transmitted to the Senate.
4/1/2021 2:01:50 PM
Returned by the Committee Do Pass
3/11/2021 5:39:58 PM
Read the first time, rules suspended, read the second time and referred to the Committee on PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE- HOUSE
3/11/2021 5:24:41 PM
RECEIVED FROM THE SENATE
3/11/2021 1:57:54 PM
Ordered immediately transmitted to the House.
3/11/2021 1:57:41 PM
Read the third time and passed.
3/10/2021 6:05:19 PM
Returned by the Committee, with the recommendation that it Do Pass
3/9/2021 1:10:50 PM
Re-referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE
3/9/2021 1:10:35 PM
REPORTED CORRECTLY ENGROSSED
3/9/2021 9:02:14 AM
Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
3/9/2021 9:02:07 AM
Withdrawn from Committee for purpose of amendment # 1
2/24/2021 3:39:25 PM
Read first time, rules suspended, read second time, referred to PUBLIC HEALTH, WELFARE AND LABOR COMMITTEE - SENATE
2/24/2021 1:01:41 PM